Figure 3
From: Evidence from a breast cancer hypofractionated schedule: late skin toxicity assessed by ultrasound

Percentage incidence of late skin toxicity.
From: Evidence from a breast cancer hypofractionated schedule: late skin toxicity assessed by ultrasound
Percentage incidence of late skin toxicity.